Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
pre market .0725
sltd has positioned itself for strong growth from here on it's anyone's guess as to the reflection of it's share price increase the current valuation has to take into consideration of what today's news stated and the forecast made Nelson states
" We have strong hopes that this activity will grow and strengthen this already dynamic division." .
" "Our future looks brighter than ever," said Jim Nelson, CEO of Solar3D. "We are very optimistic about the path we are on to achieve our ultimate mission of providing affordable and efficient solar power to the world."
Abe Emard, CEO of SUNworks, added,
"Not only are we realizing substantial results now, but our combined residential and commercial contracted backlog is well over $10MM and we anticipate adding to it substantially in the next few weeks."
Imo The market will test it's true valuation GLTA and hang on to every share or add to your position.
1st resistance .075 after breakout
thanks again moonshine1999
Thanks buckylaw06 where can i find that data?
is sltd development it's 3d cells with perovskite?
http://news.sciencemag.org/chemistry/2014/05/perovskite-solar-cells-get-lead-out
Thanks..Anyone's guess as to valuation of bmsn with this latest development in...If they were in talks with a Big Pharma what would be fair price? Just looking ahead
Don't know what to make of this anyone's guess?
Is this a pummper?
Latest Projections: Regen Share Price To Open At $1.55 When Public Trading Starts, Bio-Matrix Scientific Group (BMSN) Shareholders Await Scalable Increase To Their Share Price Projects Sierra World Equity Review.
last call to all shorts
IMO bmsn is about to gap up!!!!!
fda fast tract cannabidiol this is great news for stev$$$$
FDA grants cannabidiol-based treatment for childhood epilepsy a fast track to U.S. approval
June 9, 2014 10:40 am by NewsCred | 0 Comments
Share This Story
Share on email Share on facebook Share on twitter Share on linkedin Share on print More Sharing Services4
Biopharmaceutical company GW Pharmaceuticals(NasdaqGM:GWPH) (LSE:GWP.L) reported the receipt of the US Food and Drug Administration's (FDA) Fast Track designation for its investigational cannabidiol (CBD) product, Epidiolex, in the treatment of Dravet syndrome, a rare and catastrophic treatment- resistant form of childhood epilepsy.
The company added that a drug development programme with Fast Track designation is afforded greater access to the FDA for the purpose of expediting the drug's development, review and potential approval to get important new drugs to the patient earlier.
Concurrently, the company proposes to start a clinical development programme for Epidiolex in the treatment of Lennox- Gastaut syndrome (LGS).
Upon receipt of the US FDA's prior orphan drug designation in LGS, the company expects to hold a pre-IND meeting with the FDA for Epidiolex in the treatment of LGS in mid-2014 plus plans to conduct two Phase 3 trials in LGS during 2015.
(C)2014 M2 COMMUNICATIONS http://www.m2.com
[Image credit: Flickr user Lisa Williams]
Share This Story
Share on email Share on facebook Share on twitter Share on linkedin Share on print More Sharing Services4
Hear the latest industry news first
Get our daily newsletter or follow us.
Share on facebook Share on twitter Share on linkedin Share on rss
Please enter your email below:
By NewsCred
Visit website | More posts by Author
0 comments
Livefyre
Sign in or Post as Guest
1 person listening
Newest | Oldest | Top Comments
GOT NEWS? SEND US A TIP
Hear the latest news first
Get our daily newsletter or follow us.
Share on facebook Share on twitter Share on linkedin Share on rss
Read Next
Apple execs and FDA talk wearables and mobile device regulation nuances
Stephanie Baum
Apple execs and FDA talk wearables and mobile device regulation nuances
By Veronica Combs
Advertisement
Read more: http://medcitynews.com/2014/06/fda-grants-cannabidiol-based-treatment-childhood-epilepsy-fast-track-u-s-approval/#ixzz34ILa2T3M
Connect the dots guys do your dd http://news.yahoo.com/gene-tests-may-cancer-patients-quicker-path-treatment-054547863--sector.html
break out on charts
P.S. The trunk also has fins, as had been rumored since last year (L2) – although the reason for the fins inclusion were not explained at the reveal event.
While there is a small throwback to NASA’s MLAS fins, it is likely the Dragon V2's fins are installed for aerodynamic reasons, as opposed to the role of radiators – as was initially thought.
From the Blog Quote
"One of our most popular case studies compares various manufacturing methods for a missile component that controls flight. Supersonic missiles are highly sensitive to the exact geometry of control surfaces and precision is mission critical. Canards (French for “duck”) are the pivoting fins attached to the side body of missiles ahead of the main wing that provide stability and maneuverability for a projectile. Supersonic missiles must also shift between subsonic and supersonic speeds and canards affect the airflow against the main wing, altering the center of mass, and shifting the aerodynamic center. Thus, any deviation in geometric specifications will greatly affect flight control, causing extra turbulence and unanticipated movement.
think of lqmt sheet metal on all the new space ships developed. http://www.nasaspaceflight.com/2014/05/spacex-lifts-the-lid-dragon-v2-crew-spacecraft/
If the industry is about to change then it'll be prudent on xsnx to adapt
San Jose-based SunPower, Silicon Valley's dominant solar manufacturer, is repositioning itself as a full-service energy service provider and plans to add battery-based storage systems to its solar projects.
If xsnx was going to partner with a battery storage who would it likely to be? any thoughts? Tesla?
xsnx has to get on the ball!!http://www.mercurynews.com/business/ci_25900627/energy-storage-hot-new-thing-silicon-valley
Is xnsx in talks to partner with a battery storage co?
Barclays recently downgraded the entire U.S. electric utilities sector to "underweight" on the threat posed by widespread adoption of solar-storage. These systems allow homeowners to use rooftop solar panels and a battery to cut all but the figurative emergency backup cord to their local electric grid, putting a severe strain on an industry that has been a defacto monopoly.
IS XSNX SELLING STORAGE OR INTENDS TO? http://finance.yahoo.com/news/solar-destroy-power-companies-5-194826472.html
the largest food conglomerate in South Korea is lotte trading co website confirms that's most likely
http://www.21food.com/showroom/491025/product/raw-material-of-confectionary.html
IMO as you mentioned earlier COFCO may just be the company and GLC may be the extraction and production with recent FDA approval GRAS approved.
As a widely recognized global company, COFCO has been awarded as one of the “Fortune 500” companies for 20 consecutive years, the only Chinese agri-food enterprise on the list. COFCO’s revenues in 2012 were US$34Bn.
www.cofco.com
VANCOUVER, British Columbia—The U.S. Food and Drug Administration (FDA) issued a Generally Recognized as Safe (GRAS) letter of no objection covering several of GLG Life Tech Corporation’s high-purity stevia extracts, including its Rebsweet and AnySweetPLUS products.
The GRAS program is an FDA-approved process that enables companies to conduct independent GRAS determinations through consultations with qualified experts to determine that an ingredient satisfies the FDA's safety criteria. Accordingly, GLG engaged GRAS Associates, LLC, who convened an independent panel of expert scientists to spearhead the safety assessment and compile a dossier describing the months-long study and its results. GLG subsequently submitted that dossier to the FDA for review, resulting in the FDA's letter of no objection.
To date, GLG has received five GRAS letters of no objection covering an array of high-purity stevia products, with a sixth GRAS determination pending FDA review (for high-purity rebaudioside M) and two other GRAS projects currently underway (for high-purity rebaudioside C and D). Additionally, GLG recently announced its submission of a GRAS notification to the FDA for its Luo Han Guo (Monk Fruit) extract products. GLG currently has the largest number of stevia products certified under the GRAS process.
almost one year to date...patience pays$$$$$$$
Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program
Source Press Release
Company Bio-Matrix Scientific Group
Date June 07, 2013
Bio-Matrix Scientific Group's Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program
SAN DIEGO, CA -- (Marketwired) -- 06/07/13 -- Regen BioPharma, wholly owned subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), announced today its submission of responses to the U.S. Food and Drug Administration's (FDA) comments regarding its IND # 15376 covering the use of HemaXellerate for treatment of immune suppressant resistant aplastic anemia. As part of the response to comments, Regen BioPharma provided new data demonstrating efficacy of the HemaXellerate product at accelerating stem cell recovery after chemotherapeutic injury.
"We are pleased with the responses that we have provided to the FDA and look forward to initiating our clinical trials," stated David Koos, Chairman and CEO of Regen BioPharma. "Although it is possible that a second round of comments may be issued, we feel this process is extremely useful to creating a clinical trial that is optimized for safety and detection of efficacy."
The HemaXellerate clinical trial aims to recruit 10 patients with aplastic anemia that have not shown material signs of improvement under the current the standard of care. If successful, the company will progress to larger efficacy-finding trials, as well as expansion to other diseases that would benefit from enhancement of bone marrow stem cells.
The scientific rationale for HemaXellerate, as well as some of the supporting data, may be found in the peer reviewed publication titled "Exogenous endothelial cells as accelerators of hematopoietic reconstitution," which is available at this link http://www.translational-medicine.com/content/pdf/1479-5876-10-231.pdf
Currently there is a need for therapies that stimulate bone marrow stem cells. HemaXellerate utilizes cells derived from the patient's own fat stem cells to repair and stimulate the hematopoietic stem cells of the bone marrow, which are responsible for production of blood. The current market for therapies that stimulate blood cell production is in the billions of dollars per year. Neupogen and Neulasta, two products that stimulate production of white blood cells had sales of $4.84 Billion in 2010 http://www.wikinvest.com/stock/Amgen.
About Bio-Matrix Scientific Group, Inc. and Regen BioPharma, Inc.:
Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN) through its wholly owned subsidiary, Regen BioPharma, Inc., is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/II clinical trials. To follow our development, visit us at www.regenbiopharma.com.
Disclaimer:
This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Contact:
Bio-Matrix Scientific Group, Inc. and
Regen BioPharma Inc.
David R. Koos, PhD
Chairman & Chief Executive Officer
619-702-1404
www.regenbiopharma.com
LQMT Apple renews rights to Liquidmetal's metal alloys, MacRumors reports
Apple (AAPL) has renewed its rights to use metal alloys from Liquidmetal Technologies (LQMT) in consumer electronics items, MacRumors reports. The renewal extends the companies' agreement through February 2015. Apple is said to be interested in Liquidmetal's alloys for touch tensors and home buttons. Reference Link
just got a confirmed ema breakout
Timing is everthing
http://gigaom.com/2014/05/16/as-solar-panels-boom-it-was-the-simple-business-model-that-the-big-energy-players-missed/
http://seekingalpha.com/article/2115193-can-your-portfolio-light-up-with-some-of-these-top-performers-in-solar-and-where-do-you-think-the-market-is-headed
ALISO VIEJO, CA--(Marketwired - May 6, 2014) - XsunX, Inc. (OTCQB: XSNX), a solar energy solutions provider, today announced that it is expanding its sales force and adding new financing options for commercial solar projects in the lucrative Southern California market.
From Today's news$$$$$ To date, we are working with the largest food conglomerate in South Korea, a major importer to Europe, and we are in talks with a major Fortune 500 company to supply its South East Asian operations
Lotte has established a joint venture with Hershey's to extend the reach of products of both companies in China
Lotte Confectionery (Hangul: ????) (KRX: 004990) is a South Korean company headquartered in Yangpyeong-dong Yeongdeungpo-gu, Seoul, Korea. It was established in 1967 and its plants are located in Seoul, Daejeon, Yangsan, Pyeongtaek and Siheung. It manufactures and sells more than 200 products to more than 70 countries. It is the third largest chewing gum manufacturer in the world. It is a subsidiary company of Lotte Group.
Lotte Confectionery produces the Crunky candy bar [1] and the Chic-Choc cookie (a chocolate chip cookie), one of the most famous brands in South Korea. Additionally, they produce other baked snacks, including the Margaret cookie. Lotte is also popular for their cookies called 'Kancho' (also known as Koala's March in Japan), which are small cream-filled cookies shaped like koala bears and packaged in a unique octagonal box.
Through its wide distribution, Lotte Confectionery is able to stream products to grocery, convenience stores, mom-and-pop and warehouse clubs. Their products are also distributed worldwide, including the USA, China and Europe.
It is a sister company of leading Polish confectionery company E. Wedel after the parent Lotte group completed a takeover from Kraft Foods in June 2010.[
The future is now when it comes to stevia
http://www.foodnavigator.com/Product-Categories/Sweeteners-intense-bulk-polyols
did they halt trading?
http://www.benitec.com/asx-releases.php Regen was highlighted in the presentation
ASTRA--ZENECA
PRESENTATION
Sydney,
Australia,
30
April
2014
Benitec
Biopharma’s
CEO
and
Managing
Director
Dr
Peter
French
has
been
invited
by
Astra--Zeneca
Australia
to
present
to
a
group
of
senior
medical
specialists
in
Adelaide
on
Wednesday
evening,
30
April
2014.
He
will
be
presenting
on
two
subjects:
“The
Art
of
Silencing
Genes”
and
“ddRNAi--
Now
and
into
the
future”.
This
will
be
followed
by
a
Q&A
with
the
guests.
impressive site like the galleries of some of the company completed projects http://www.visitsunworks.com/index.php
Jim Nelson, CEO of Solar3D. "We had no idea how significant the growth would be. With the level of new agricultural and commercial project sales activity that SUNworks is currently experiencing, we believe that the company's rate of growth this year will exceed that of any previous year."
P.S.notice Nelson comments on this growth is just based on the current developments of sltd he didn't take into factor of future projects!!!!
anyone knows completion dates and the amount of revenue generated from these projects?
"we are in the process of completing a number of other agricultural projects, including Dutra Dairy, Borges Dairy, Conant Orchards, Gilbert Ranch, and Roy Moreso, Inc."
"This is just the beginning of some very large projects$$$$$$$ that our agricultural and commercial divisions are working on," reported Abe Emard, CEO of SUNworks.
Didn't realize xsnx was still marketing the cigs production plant
Despite the broader markets' uncertainty.... sltd fundamentals are strong and remains strong to stay long ....this is a winner.
Stong buy and stay long.
At XsunX, our thin film solar cell manufacturing technology development efforts center on delivering a lower cost, entry point solution for the manufacture of thin film CIGS (copper indium gallium selenide) solar cells.
This at a time when the solar market is heating up that's huge for xsnx
Did I miss something???To learn more about CIGSolar® and how we can tailor fit and build a CIGSolar® manufacturing solution to fit your PV manufacturing plans please visit our CIGSolar®